Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of ICXP007 with four-layer compression for venous leg ulcers
2004-002122-22Phase 3Completed
- Sponsor
- Intercytex Group
- Start
- May 2005
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ICXP007 in stasis ulcer and venous stasis (3 arms), sponsored by Intercytex Group. Primary endpoint: Incidence of complete ulcer healing. Started May 2005; status: completed.
02
Drugs
ICXP007
03
Conditions
stasis ulcervenous stasis
Beyond the preview
Go deeper on 2004-002122-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002122-22.